AI Terminal
Indivior PLC
Investor Presentation • Sep 6, 2023
4923_rns_2023-09-06_17e6aaef-ed68-4bb7-a9ac-49f06ff855b1.html
Investor Presentation
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6060L
Indivior PLC
06 September 2023
Indivior To Participate in Upcoming Investor Events
Slough, UK, and Richmond, VA, September 6, 2023 - Indivior PLC (LSE/NASDAQ: INDV) today announced that it will participate in the following investor events:
· Morgan Stanley 21st Annual Global Healthcare Conference - New York City
Mark Crossley, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Monday, September 11th. Mark Crossley will participate in a fireside chat at 10:40 a.m. US EDT. Interested investors should contact their Morgan Stanley representative to schedule a meeting. The fireside chat will be publicly available and can be viewed using the following weblink:
· Jefferies Global Healthcare Fireside Chat Series - Virtual
Mark Crossley, Chief Executive Officer, will participate in a fireside chat on Friday, September 22nd at 14:00 BST (9:00 a.m. US EST). The fireside chat will be publicly available and can be viewed using the following weblink:
Both events will also be accessible at www.indivior.com under the "Investors" section.
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of substance use disorder (SUD). Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 1,000 individuals globally and its portfolio of products is available in 39 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or [email protected]
Tim Owens
Director, Investor Relations
Tel: 804-263-3978 or [email protected]
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFLFVVADIRIIV